APRINOIA THERAPEUTICS INC.
Update：2026/09/15
Industries
Main Industry
Biotechnology
Main Product/Service
APRINOIA THERAPEUTICS INC. is dedicated to the research and development of world-class diagnostic technologies and therapeutics for Alzheimer's disease (AD) and other Tau protein-related neurodegenerative diseases (tauopathies).
(The content above was translated by AI.)
(The content above was translated by AI.)
Founded Year
2015
Unified Business No.
24969508
Status
Closed
Number of Employees
0
Total Paid-in
Capital
0 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
APRINOIA is a biotechnology company with a deep research foundation, dedicated to providing best-in-class diagnostic tools and novel therapies, improving the treatment outcomes of various neurodegenerative diseases, and protecting patients' brain health.
The English name of APRINOIA, "APRINOIA", is a combination of the Latin word "apricum", which symbolizes sunshine, and the Greek suffix "noia", which means "mind". The company name highlights our mission: in the face of dreadful neurodegenerative diseases, we actively explore the path of developing better diagnostic and therapeutic drugs to realize the company's vision of utilizing these novel diagnostic tools and targeted therapeutic drugs to provide a better future for patients.
(The content above was translated by AI.)
The English name of APRINOIA, "APRINOIA", is a combination of the Latin word "apricum", which symbolizes sunshine, and the Greek suffix "noia", which means "mind". The company name highlights our mission: in the face of dreadful neurodegenerative diseases, we actively explore the path of developing better diagnostic and therapeutic drugs to realize the company's vision of utilizing these novel diagnostic tools and targeted therapeutic drugs to provide a better future for patients.
(The content above was translated by AI.)
